The DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.
miR‐181b modulates multidrug resistance by targeting BCL2 in human cancer cell lines
Open accessAbstract
MicroRNAs (miRNAs) are short noncoding RNA molecules, which posttranscriptionally regulate genes expression and play crucial roles in diverse biological processes, such as development, differentiation, apoptosis and proliferation. Here, we investigated the possible role of miRNAs in the development of multidrug resistance (MDR) in human gastric and lung cancer cell lines. We found that miR‐181b was downregulated in both multidrug‐resistant human gastric cancer cell line SGC7901/vincristine (VCR) and multidrug‐resistant human lung cancer cell line A549/cisplatin (CDDP), and the downregulation of miR‐181b in SGC7901/VCR and A549/CDDP cells was concurrent with the upregulation of BCL2 protein, compared with the parental SGC7901 and A549 cell lines, respectively. In vitro drug sensitivity assay demonstrated that overexpression of miR‐181b sensitized SGC7901/VCR and A549/CDDP cells to anticancer drugs, respectively. The luciferase activity of a BCL2 3′‐untranslated region‐based reporter construct in SGC7901/VCR and A549/CDDP cells suggests that a new target site in the 3′UTR of BCL2 of the mature miR‐181s (miR‐181a, miR‐181b, miR‐181c and miR‐181d) was found. Enforced miR‐181b expression reduced BCL2 protein level and sensitized SGC7901/VCR and A549/CDDP cells to VCR‐induced and CDDP‐induced apoptosis, respectively. Taken together, our findings suggest that miR‐181b could play a role in the development of MDR in both gastric and lung cancer cell lines, at least in part, by modulation of apoptosis via targeting BCL2.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method
Livak, K. J., & Schmittgen, T. D. (2001) · Methods · doi:10.1006/meth.2001.1262 · Cited by 180,860
Real-time quantification of microRNAs by stem-loop RT-PCR
Chen, C. (2005) · Nucleic Acids Research · doi:10.1093/nar/gni178 · Cited by 4,952
Targeting multidrug resistance in cancer
Szakács, G., Paterson, J. K., Ludwig, J. A., Booth-Genthe, C., & Gottesman, M. M. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd1984 · Cited by 3,609
MicroRNAs Modulate Hematopoietic Lineage Differentiation
Chen, C.-Z., Li, L., Lodish, H. F., & Bartel, D. P. (2004) · Science · doi:10.1126/science.1091903 · Cited by 3,257 · cited 1×
“Function research of miR-181s was first focused on hematopoietic lineage differentiation in mouse, and mmu-miR181s was reported to show an obviously high expression at the adult stage, compared with embryonic and early postnatal stages in hematopoietic lineage differentiation.(28) Recent studies by Fanini et al.”
ResultJohnstone (2002) · doi:10.1016/s0092-8674(02)00625-6 · Cited by 1,876
Si, M.-L., Zhu, S., Wu, H., Lu, Z., Wu, F., & Mo, Y.-Y. (2007) · Oncogene · doi:10.1038/sj.onc.1210083 · Cited by 1,600
Molecular mechanisms of resistance and toxicity associated with platinating agents
Rabik, C. A., & Dolan, M. E. (2007) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2006.09.006 · Cited by 1,564
MicroRNAs in cell proliferation, cell death, and tumorigenesis
Hwang, H.-W., & Mendell, J. T. (2006) · British Journal of Cancer · doi:10.1038/sj.bjc.6603023 · Cited by 1,399
miR‐15b and miR‐16 modulate multidrug resistance by targeting BCL2 in human gastric cancer cells
Xia, L., Zhang, D., Du, R., Pan, Y., Zhao, L., Sun, S., Hong, L., Liu, J., & Fan, D. (2008) · International Journal of Cancer · doi:10.1002/ijc.23501 · Cited by 711
Kovalchuk, O., Filkowski, J., Meservy, J., Ilnytskyy, Y., Tryndyak, V. P., Chekhun, V. F., & Pogribny, I. P. (2008) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-08-0021 · Cited by 635
Cited by
Shen, D.-W., Pouliot, L. M., Hall, M. D., & Gottesman, M. M. (2012) · Pharmacological Reviews · doi:10.1124/pr.111.005637 · Cited by 955
The role and mechanisms of action of microRNAs in cancer drug resistance
Si, W., Shen, J., Zheng, H., & Fan, W. (2019) · Clinical Epigenetics · doi:10.1186/s13148-018-0587-8 · Cited by 668
Collino, F., Deregibus, M. C., Bruno, S., Sterpone, L., Aghemo, G., Viltono, L., Tetta, C., & Camussi, G. (2010) · PLoS ONE · doi:10.1371/journal.pone.0011803 · Cited by 608
Noncoding RNAs in gastric cancer: implications for drug resistance
Wei, L., Sun, J., Zhang, N., Zheng, Y., Wang, X., Lv, L., Liu, J., Xu, Y., Shen, Y., & Yang, M. (2020) · Molecular Cancer · doi:10.1186/s12943-020-01185-7 · Cited by 468
MicroRNA-181b regulates NF-κB–mediated vascular inflammation
Sun, X., Icli, B., Wara, A. K., Belkin, N., He, S., Kobzik, L., Hunninghake, G. M., Vera, M. P., Blackwell, T. S., Baron, R. M., et al. (2012) · Journal of Clinical Investigation · doi:10.1172/jci61495 · Cited by 444
Molecular mechanisms of drug resistance and its reversal in cancer
Kartal-Yandim, M., Adan-Gokbulut, A., & Baran, Y. (2016) · Critical Reviews in Biotechnology · doi:10.3109/07388551.2015.1015957 · Cited by 346
The role of exosomes and miRNAs in drug‐resistance of cancer cells
Bach, D., Hong, J., Park, H. J., & Lee, S. K. (2017) · International Journal of Cancer · doi:10.1002/ijc.30669 · Cited by 296
TGF-β upregulates miR-181a expression to promote breast cancer metastasis
Taylor, M. A., Sossey-Alaoui, K., Thompson, C. L., Danielpour, D., & Schiemann, W. P. (2013) · Journal of Clinical Investigation · doi:10.1172/jci64946 · Cited by 288
Drug resistance in cancer: mechanisms and tackling strategies
Haider, T., Pandey, V., Banjare, N., Gupta, P. N., & Soni, V. (2020) · Pharmacological Reports · doi:10.1007/s43440-020-00138-7 · Cited by 282
MicroRNA dysregulation in gastric cancer: a new player enters the game
Wu, W. K. K., Lee, C. W., Cho, C. H., Fan, D., Wu, K., Yu, J., & Sung, J. J. Y. (2010) · Oncogene · doi:10.1038/onc.2010.352 · Cited by 277
Taxane resistance in breast cancer: mechanisms, predictive biomarkers and circumvention strategies.
Murray, S., Briasoulis, E., Linardou, H., Bafaloukos, D., & Papadimitriou, C. (2012) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2012.02.011 · Cited by 261
MicroRNA regulation of core apoptosis pathways in cancer
Lima, R. T., Busacca, S., Almeida, G. M., Gaudino, G., Fennell, D. A., & Vasconcelos, M. H. (2011) · European Journal of Cancer · doi:10.1016/j.ejca.2010.11.005 · Cited by 260
miR-497 modulates multidrug resistance of human cancer cell lines by targeting BCL2
Zhu, W., Zhu, D., Lu, S., Wang, T., Wang, J., Jiang, B., Shu, Y., & Liu, P. (2012) · Medical Oncology · doi:10.1007/s12032-010-9797-4 · Cited by 189
Self-citation
Metadata
- Authors
- Zhu, W., Shan, X., Wang, T., Shu, Y., & Liu, P.
- Venue
- International Journal of Cancer
- Publisher
- Wiley
- Published
- 2010-02-16
- Volume
- 127
- Issue
- 11
- Pages
- 2520-2529
- ISSN
- 0020-7136 (ISSN-L)
- 1097-0215
- OpenAlex
- W2032801961
- Cited by
- 299
- References
- 33
- FWCI
- 9.75
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.